Keywords
- CREB Phosphorylation
- Enhance Cyan Fluorescent Protein
- Human Fibroblast Growth Factor
- Alternative Translation Start Site
- Intracrine Action
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, access via your institution.
Buying options
Preview
Unable to display preview. Download preview PDF.
References
Cook JL, Giardina JF, Zhang Z, Re RN. Intracellular Angiotensin II Increases the Long Isoform of PDGF mRNA in Rat Hepatoma Cells. J Mol Cell Cardiol. 2002;34:1525–37.
Cook JL, Re R, Alam J, Hart M, Zhang Z. Intracellular angiotensin II fusion protein alters AT1 receptor fusion protein distribution and activates CREB. J Mol Cell Cardiol. 2004;36:75–90.
Cook JL, Zhang Z, Re RN. In vitro evidence for an intracellular site of angiotensin action. Circ Res. 2001;89:1138–46.
Re RN. The intracrine hypothesis and intracellular peptide hormone action. Bioessays. 2003;25:401–9.
Re RN. Tissue renin angiotensin systems. Med Clin North Am. 2004;88:19–38.
Lynch KR, Simnad VI, Ben-Ari ET, Garrison JC. Localization of preangiotensinogen messenger RNA sequences in the rat brain. Hypertension. 1986;8:540–3.
Aronheim A, Engelberg D, Li N, al-Alawi N, Schlessinger J, Karin M. Membrane targeting of the nucleotide exchange factor Sos is sufficient for activating the Ras signaling pathway. Cell. 1994;78:949–61.
Hancock JF, Cadwallader K, Paterson H, Marshall CJ. A CAAX or a CAAL motif and a second signal are sufficient for plasma membrane targeting of ras proteins. Embo J. 1991;10:4033–9.
Chui DH, Tang W, Orkin SH. cDNA cloning of murine Nrf 2 gene, coding for a p45 NF-E2 related transcription factor. Biochem Biophys Res Commun. 1995;209:40–6.
Arnaud E, Touriol C, Boutonnet C, Gensac MC, Vagner S, Prats H, Prats AC. A new 34-kilodalton isoform of human fibroblast growth factor 2 is cap dependently synthesized by using a non-AUG start codon and behaves as a survival factor. Mol Cell Biol. 1999;19:505–14.
Hann SR, Dixit M, Sears RC, Sealy L. The alternatively initiated c-Myc proteins differentially regulate transcription through a noncanonical DNA-binding site. Genes Dev. 1994;8:2441–52.
Kiefer P, Acland P, Pappin D, Peters G, Dickson C. Competition between nuclear localization and secretory signals determines the subcellular fate of a single CUG-initiated form of FGF3. Embo J. 1994;13:4126–36.
Nguyen M, He B, Karaplis A. Nuclear forms of parathyroid hormone-related peptide are translated from non-AUG start sites downstream from the initiator methionine. Endocrinology. 2001;142:694–703.
Vagner S, Gensac MC, Maret A, Bayard F, Amalric F, Prats H, Prats AC. Alternative translation of human fibroblast growth factor 2 mRNA occurs by internal entry of ribosomes. Mol Cell Biol. 1995;15:35–44.
Martoglio B. Intramembrane proteolysis and post-targeting functions of signal peptides. Biochem Soc Trans. 2003;31:1243–7.
Nagai K, Oubridge C, Kuglstatter A, Menichelli E, Isel C, Jovine L. Structure, function and evolution of the signal recognition particle. Embo J. 2003;22:3479–85.
Campbell DJ, Bouhnik J, Coezy E, Menard J, Corvol P. Processing of rat and human angiotensinogen precursors by microsomal membranes. Mol Cell Endocrinol. 1985;43:31–40.
Campbell DJ, Bouhnik J, Menard J, Corvol P. Identity of angiotensinogen precursors of rat brain and liver. Nature. 1984;308:206–8.
Campbell DJ, Bouhnik J, Coezy E, Pinet F, Clauser E, Menard J, Corvol P. Characterization of precursor and secreted forms of rat angiotensinogen. Endocrinology. 1984;114:776–85.
Kozak M. Context effects and inefficient initiation at non-AUG codons in eucaryotic cell-free translation systems. Mol Cell Biol. 1989;9:5073–80.
Mehdi H, Ono E, Gupta KC. Initiation of translation at CUG, GUG, and ACG codons in mammalian cells. Gene. 1990;91:173–8.
Tewksbury DA, Pan N, Kaiser SJ. Detection of a receptor for angiotensinogen on placental cells. Am J Hypertens. 2003;16:59–62.
Mercure C, Ramla D, Garcia R, Thibault G, Deschepper CF, Reudelhuber TL. Evidence for intracellular generation of angiotensin II in rat juxtaglomerular cells. FEBS Lett. 1998;422:395–9.
Peters J, Farrenkopf R, Clausmeyer S, Zimmer J, Kantachuvesiri S, Sharp MG, Mullins JJ. Functional significance of prorenin internalization in the rat heart. Circ Res. 2002;90:1135–41.
Heldin CH, Ericsson J. Signal transduction. RIPping tyrosine kinase receptors apart. Science. 2001;294:2111–3.
Waugh MG, Hsuan JJ. EGF receptors as transcription factors: ridiculous or sublime? Nat Cell Biol. 2001;3:E209–11.
Wells A, Marti U. Signalling shortcuts: cell-surface receptors in the nucleus? Nat Rev Mol Cell Biol. 2002;3:697–702.
Lu D, Yang H, Shaw G, Raizada MK. Angiotensin II-induced nuclear targeting of the angiotensin type 1 (AT1) receptor in brain neurons. Endocrinology. 1998;139:365–75.
Nikiforovich GV, Marshall GR. 3D model for TM region of the AT-1 receptor in complex with angiotensin II independently validated by site-directed mutagenesis data. Biochem Biophys Res Commun. 2001;286:1204–11.
Wilkes BC, Masaro L, Schiller PW, Carpenter KA. Angiotensin II vs its type I antagonists: conformational requirements for receptor binding assessed from NMR spectroscopic and receptor docking experiments. J Med Chem. 2002;45:4410–8.
Tzakos AG, Bonvin AM, Troganis A, Cordopatis P, Amzel ML, Gerothanassis IP, Van Nuland NA. On the molecular basis of the recognition of angiotensin II (AII). Eur J Biochem. 2003;270:849–860.
Hunyady L, Baukal AJ, Gaborik Z, Olivares-Reyes JA, Bor M, Szaszak M, Lodge R, Catt KJ, Balla T. Differential PI 3-kinase dependence of early and late phases of recycling of the internalized AT1 angiotensin receptor. J Cell Biol. 2002;157:1211–22.
Yadav SP, Karnick S, Shen WZ, Zhang J. Characterization of Rhodamine Conjugated Agiotensin II Peptide: Synthesis, Analysis and Receptor Binding and Internalization. Protein Pept Lett. 2002;9:465–76.
Betsholtz C, Johnsson A, Heldin CH, Westermark B, Lind P, Urdea MS, Eddy R, Shows TB, Philpott K, Mellor AL. cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines. Nature. 1986;320:695–9.
Pierce GF, Tarpley JE, Tseng J, Bready J, Chang D, Kenney WC, Rudolph R, Robson MC, Vande Berg J, Reid P. Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing wounds. J Clin Invest. 1995;96:1336–50.
Tong BD, Auer DE, Jaye M, Kaplow JM, Ricca G, McConathy E, Drohan W, Deuel TF. cDNA clones reveal differences between human glial and endothelial cell platelet-derived growth factor A-chains. Nature. 1987;328:619–21.
Funakoshi Y, Ichiki T, Takeda K, Tokuno T, Iino N, Takeshita A. Critical role of cAMP-response element-binding protein for angiotensin II-induced hypertrophy of vascular smooth muscle cells. J Biol Chem. 2002;277:18710–7.
Reddy MA, Thimmalapura PR, Lanting L, Nadler JL, Fatima S, Natarajan R. The oxidized lipid and lipoxygenase product 12(S)-hydroxyeicosatetraenoic acid induces hypertrophy and fibronectin transcription in vascular smooth muscle cells via p38 MAPK and cAMP response element-binding protein activation. Mediation of angiotensin II effects. J Biol Chem. 2002;277:9920–8.
Cammarota M, Bevilaqua LR, Dunkley PR, Rostas JA. Angiotensin II promotes the phosphorylation of cyclic AMP-responsive element binding protein (CREB) at Ser133 through an ERK1/2-dependent mechanism. J Neurochem. 2001;79:1122–8.
Re RN. Intracellular renin and the nature of intracrine enzymes. Hypertension. 2003;42:117–22.
Re RN. Toward a theory of intracrine hormone action. Regul Pept. 2002;106:1–6.
Mittelman JM, Gudkov AV. Generation of p53 suppressor peptide from the fragment of p53 protein. Somat Cell Mol Genet. 1999;25:115–28.
Sherrod M, Liu X, Zhang X, Sigmund CD. Nuclear Localization of Angiotensinogen in Astrocytes. Am J Physiol Regul Integr Comp Physiol. 2005;288:R539–546.
Baker KM, Chernin MI, Schreiber T, Sanghi S, Haiderzaidi S, Booz GW, Dostal DE, Kumar R. Evidence of a novel intracrine mechanism in angiotensin II-induced cardiac hypertrophy. Regul Pept. 2004;120:5–13.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Science+Business Media, Inc.
About this paper
Cite this paper
Cook, J.L., Re, R.N. (2006). Lessons from Experimental Generation of Intracellular Angiotensinogen and AII. In: Frohlich, E.D., Re, R.N. (eds) The Local Cardiac Renin Angiotensin-Aldosterone System. Basic Science for the Cardiologist, vol 20. Springer, Boston, MA. https://doi.org/10.1007/0-387-27826-5_7
Download citation
DOI: https://doi.org/10.1007/0-387-27826-5_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-27825-4
Online ISBN: 978-0-387-27826-1
eBook Packages: MedicineMedicine (R0)